切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2016, Vol. 04 ›› Issue (01) : 45 -47. doi: 10.3877/cma.j.issn.2095-655X.2016.01.013

所属专题: 文献

临床研究

胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义
李凯1, 赵卫星1, 鲍永华2, 杨万才3,()   
  1. 1. 453100 新乡医学院第一附属医院病理科
    2. 453003 新乡医学院基础医学院免疫学教研室
    3. 453003 新乡医学院基础医学院病理教研室
  • 收稿日期:2015-12-03 出版日期:2016-02-26
  • 通信作者: 杨万才
  • 基金资助:
    国家自然科学基金(91229115)

The serum levels of PRSS8 and their clinical significance in the patients with gastritis, esophagitis and esophageal cancer

Kai Li1, Weixing Zhao1, Yonghua Bao2, Wancai Yang3,()   

  1. 1. Department of Pathology, the First Affiliated Hospital of Xinxiang Medical University, Weihui 453100
    2. Department of Immunology, Xinxiang Medical University, Xinxiang 453003, China
    3. Department of Pathology, Xinxiang Medical University, Xinxiang 453003, China
  • Received:2015-12-03 Published:2016-02-26
  • Corresponding author: Wancai Yang
  • About author:
    Corresponding author: Yang Wancai, Email:
引用本文:

李凯, 赵卫星, 鲍永华, 杨万才. 胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义[J/OL]. 中华诊断学电子杂志, 2016, 04(01): 45-47.

Kai Li, Weixing Zhao, Yonghua Bao, Wancai Yang. The serum levels of PRSS8 and their clinical significance in the patients with gastritis, esophagitis and esophageal cancer[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(01): 45-47.

目的

探讨人丝氨酸蛋白酶8(PRSS8)在胃炎、食管炎和食管癌患者血清中的表达情况及意义。

方法

采集临床诊断为食管炎、食管癌和胃炎患者以及正常人群的血清样本,其中食管炎患者血清样本20例,食管癌患者血清样本6例,胃炎患者血清样本60例,正常血清样本28例。采用酶联免疫吸附法(ELISA)的方法测定各组中PRSS8的表达水平,并将食管炎患者组、食管癌患者组和胃炎患者组分别与正常组相比较。

结果

各组血清PRSS8表达水平差异有统计学意义(F=13.24,P<0.01)。食管炎患者组PRSS8表达水平[(4.58±1.67)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.59,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.54,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于食管炎患者组[(4.58±1.67)μg/L],差异无统计学意义(LSD-t=0.83,P>0.05);胃炎患者组PRSS8表达水平[(5.39±1.04)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=6.22,P<0.05)。

结论

食管炎、食管癌和胃炎患者血清中PRSS8表达水平均增高,提示血清中的PRSS8可能与食管炎、食管癌和胃炎的发生发展相关。

Objective

To study the expression level and significance of serum human protease serine 8(PRSS8) in the patient with gastritis, esophagitis and esophageal cancer.

Methods

The serum samples from healthy subjects and the patients diagnosed as esophagitis, esophageal cancer and gastritis were collected.The serum samples included 20 esophagitis serum samples, 6 esophageal cancer serum samples, 60 gastritis serum samples and 28 healthy serum samples.The expression level of PRSS8 was detected by ELISA assay.Then the serum PRSS8 levels from the esophagitis group, esophageal cancer group and the gastritis group were compared with the healthy group, respectively.

Results

The serum level of PRSS8 in esophagitis group [(4.58±1.67)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.59, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.54, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the esophagitis group [(4.58±1.67)μg/L], the difference was not statistically significant(LSD-t=0.83, P>0.05). The level of serum PRSS8 in gastritis group [(5.39±1.04)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was also statistically significant (LSD-t=6.22, P<0.05).

Conclusion

Serum PRSS8 expression levels are obviously increased in the patients with esophagitis, esophageal cancer and gastritis, which suggests that serum PRRS8 maybe relate to the development of esophagitis, esophageal cancer and gastritis.

表1 各组间血清PRSS8水平比较(μg/L,±s)
[1]
Yu JX,Chao L,Chao J. Prostasin is a novel human serine protease from seminal fluid.Purification, tissue distribution, and localization in prostate gland[J]. J biol chem, 1994, 269(29): 18843-18848.
[2]
Hooper JD,Bowen N,Marshall H, et al.Localization, expression and genomic structure of the gene encoding the human serine protease testisin[J]. Biochim Biophys Acta, 2000, 1492(1): 63-71.
[3]
Yu JX,Chao L,Ward DC, et al.Structure and chromosomal localization of the human prostasin (PRSS8) gene[J]. Genomics, 1996, 32(3): 334-340.
[4]
Yu JX,Chao L,Chao J. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA[J]. J Biol Chem, 1995, 270(22): 13483-13489.
[5]
Leyvraz C,Charles RP,Rubera I, et al.The epidermal barrier function is dependent on the serine protease CAP1/Prss8[J]. J Cell Biol, 2005, 170(3): 487-496.
[6]
Buzza MS,Martin EW,Driesbaugh KH, et al.Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway[J]. J Biol Chem, 2013, 288(15): 10328-10337.
[7]
Chen LM,Hatfield ML,Fu YY, et al.Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells[J]. Prostate, 2009, 69(16): 1790-1801.
[8]
Chen LM,Wang C,Chen M, et al.Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation[J]. Am J Physiol Renal Physiol, 2006, 291(3): F567-577.
[9]
Sakashita K,Mimori K,Tanaka F, et al.Clinical significance of low expression of prostasin mRNA in human gastric cancer[J]. J Surg Oncol, 2008, 98(7): 559-564.
[10]
Takahashi S,Suzuki S,Inaguma S, et al.Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers[J]. Prostate, 2003, 54(3): 187-193.
[11]
Chen LM,Verity NJ,Chai KX.Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT) [J]. BMC cancer, 2009(9): 377.
[12]
Chen LM,Chai KX.Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation[J]. Int J Cancer, 2002, 97(3): 323-329.
[13]
López-Otín C,Matrisian LM.Emerging roles of proteases in tumour suppression[J]. Nat Rev Cancer, 2007, 7(10): 800-808.
[14]
Sarojini S,Tamir A,Lim H, et al.Early detection biomarkers for ovarian cancer[J]. J Oncol, 2012: 709049.
[15]
Yan BX,Ma JX,Zhang J, et al.Prostasin may contribute to chem oresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin[J]. Cell Death Dis, 2014(5): e995.
[16]
Chen PX,Li QY,Yang Z. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma[J]. Ann Diagn Pathol, 2013, 17(5): 425-429.
[1] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 李康虎, 王继伟, 王光远. 腹腔镜下腹股沟疝修补术后并发症及防治进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 369-375.
[4] 邓杨, 彭豪, 刘剑文. 腹腔镜疝修补术腹膜前负压引流的效果和长期安全性研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 402-405.
[5] 申亚伟, 黄新, 李万林. 改良医用胶粘合假疝囊技术预防腹腔镜完全腹膜外疝修补术后血清肿的临床研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 410-413.
[6] 张春玉, 陈海云, 肖忠萍, 罗琴, 潘运昌. 血清NT-proBNP 预测肺栓塞心脏功能障碍的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 805-808.
[7] 井发红, 李丽娜, 高婷, 高艳梅, 杨楠, 李卓, 慕玉东. 肺癌立体定向放疗血清SAP 和MMPs 表达及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 707-713.
[8] 刘思含, 张静. 老年人血清铁与C 反应蛋白的比值及25-羟基维生素D3 与肾功能受损的关系研究[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 268-272.
[9] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[10] 李润东, 豆小文, 张秀明. 失笑散联合胃复春治疗慢性萎缩性胃炎的疗效及对血清免疫受体和炎症因子水平的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 470-473.
[11] 杨菲, 刘腾飞, 赵志军, 李睿聪, 张颉, 刘妍, 赵珍. 血清维生素水平与分化型甲状腺癌的关联性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 633-640.
[12] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[13] 田峰瑞, 蒋锦源, 李阳, 张连阳. Morel-Lavallée 损伤继发血清肿一例[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 245-248.
[14] 胡瑞芳, 樊丽娟. 食管鳞状上皮内瘤变诊断的生物标志物研究进展及其非内镜治疗现状[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 281-286.
[15] 刘昌恩, 李岩, 张其德. 基于内镜筛查发现的自身免疫性胃炎的临床特征分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 233-237.
阅读次数
全文


摘要